Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral pyridostigmine for postoperative ileus after abdominal surgery
IRCT20180123038484N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of pyridostigmine in postoperative ileus (POI) (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Treatment effect time and Treatment effect frequency. Started Jan 2015; status: completed.
02
Drugs
pyridostigmine
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on IRCT20180123038484N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180123038484N1.